Acknowledgements
Cancer
ONCOLOGY, BREAST, CANCER
The authors thank the patients and their families, the staff members of the trial partners (Breast International Group, NRG Oncology, Frontier Science, AstraZeneca, Merck Sharp & Dohme, and the National Cancer Institute), the current and former members of the trial committees, and the investigators. Medical writing support, under the direction of the authors in accordance with guidelines for Good Publication Practice, was provided by Lorena Tonarelli, M.Sc., Tamsin Chambers, Ph.D., and Aaron Borg, Ph.D., of PharmaGenesis Cambridge, Cambridge, UK, and was funded by AstraZeneca, as part of an alliance between AstraZeneca and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. Additional medical writing support was also provided by Suzanne Patel, Ph.D., of BOLDSCIENCE.